
Philippines: Food and Drug Administration (FDA) issues Guidelines on the Regulatory Flexibility for Class B, C and D Medical Devices not included in the Registrable List of Medical Devices
In consideration of the challenges brought about by the full implementation of AO 2018-002, the FDA recognizes that there is a need to provide medical device companies more time to prepare the technical documentary requirements based on the ASEAN Common submission dossier template (CSDT) in applying for CMDR. With this,




